Basic Information
Basic information for C5orf64-216-57aa
Peptide Name C5orf64-216-57aa
Genome Position chr5:61755931-61755944,61757151-61757307[+]
Species Human
Peptide Sequence MGSGRDSHLLHGISTRVKREDKGSCREFHGLGLEVPYSTAACVPEGSRTATRDCKGS
Peptide Length 57
Unique No (C5orf64-209-57aa,C5orf64-212-57aa,C5orf64-214-57aa,C5orf64-220-57aa,C5orf64-227-57aa,C5orf64-228-57aa)
Grand Average of Hydropathicity -0.6842
Relative Molecular Mass 7113.8
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000178722;C5orf64
Transcript ID/Name ENST00000665180;C5orf64-216
Transcript Length 5946
Coding Ability 0.4391
DNA Sequence Corresponding to Peptide ATGGGATCTGGGAGGGACTCCCATCTTCTGCATGGCATCAGCACAAGGGTGAAGAGGGAAGATAAAGGATCATGCAGGGAGTTTCATGGACTAGGCCTGGAAGTGCCATATTCCACTGCTGCTTGTGTTCCAGAAGGCAGCCGCACAGCCACAAGGGATTGTAAAGGAAGC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :